
Clinical Briefs
Tucatinib Maintenance Approval Needs Source Verification
The supplied FDA index does not provide enough decision-specific information to verify a new tucatinib, trastuzumab and pertuzumab maintenance indication.
Rayan Salih · October 14, 2026 · 6 min
